Members of a family of Ru(II)-appended pyrenylethynylene dyads were synthesized, characterized according to their photophysical and photobiological properties, and evaluated for their collective potential as photosensitizers for metal-organic photodynamic therapy. The dyads in this series possess lowest-lying 3IL-based excited states with lifetimes that can be tuned from 22 to 270 μs in fluid solution and from 44 to 3440 μs in glass at 77 K. To our knowledge, these excited state lifetimes are the longest reported for Ru(II)-based dyads containing only one organic chromophore and lacking terminal diimine groups. These excited states proved to be extremely sensitive to trace amounts of oxygen, owing to their long lifetimes and very low radiative rates. Herein, we demonstrate that 3IL states of this nature are potent photodynamic agents, exhibiting the largest photocytotoxicity indices reported to date at nanomolar concentrations. Importantly, these new agents are robust enough to maintain submicromolar PDT in pigmented metastatic melanoma cells, where the presence of melanin in combination with low oxygen tension is known to compromise PDT. This activity underscores the potential of metal-organic PDT as an alternate treatment strategy for challenging environments such as malignant melanoma.
Read more … Exploitation of Long-Lived Triplet IL Excited States for Metal-Organic Photodynamic Therapy: Verification in a Metastatic Melanoma Model
Combination of Ru(II) Complexes and Light: New Frontiers in Cancer Therapy. Chem. Sci., 2015, 6, 2660-2686.
Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapy. Coord. Chem. Rev., 2015, 282-283, 110-126.
RutheniumII Complexes bearing Fused Polycyclic Ligands: From Fundamental Aspects to Potential Applications. Mol., 2014, 19(4), 5028-5087.
Light-Activated Metal Complexes that Covalently Modify DNA. Isr. J. Chem., 2013, 53(6-7), 391-400.